• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Hong Kong·Basic Materials·1332.HK
Share

Touyun Biotech Group Limited Stocks

HK$ 0.14Last Updated 24.07.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

HK$ 59.77M

HK$ 0.14
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Touyun Biotech Group Limited functions as a diversified investment holding company, primarily focused on the global design, development, manufacturing, and sale of a wide array of packaging products. Its market presence extends across Hong Kong, the People's Republic of China, Europe, North and South America, and other international territories. The company's operations are divided into four main business segments. The QR Code Business provides comprehensive solutions, including QR codes for product packaging and advertising display services. The Packaging Products segment specializes in creating and selling items such as luxury watch and jewelry boxes, eyewear cases, various bags and pouches, and retail display units. The Treasury Investment segment is engaged in the investment and trading of securities, alongside offering financial services like money lending, placing and underwriting, securities brokerage, asset management, and margin financing. Additionally, the Chlamydomonas Reinhardtii Product Business segment focuses on cultivating and marketing Chlamydomonas reinhardtii micro-algae and associated products. Beyond these core activities, the group also offers business intelligence IT solutions, online advertising display, and corporate management services. Established in 1989 and headquartered in Wan Chai, Hong Kong, the company transitioned to its current name, Touyun Biotech Group Limited, in May 2021, having previously been known as China Touyun Tech Group Limited.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

25.07.2026 13:01

The "Three Seas" Risk Zone, Tesla Hit by Expenses, and "Odyssey" — the Driving Force Behind Movie Theaters

25.07.2026 08:00

AI Spending Threatens the Creditworthiness of Amazon, Meta, and Alphabet — Moody’s

25.07.2026 06:24

In July, four out of five of the short seller's bets from *The Short Game* paid off. Which ones?

25.07.2026 05:59

Nvidia and Palantir Urged the U.S. Not to Restrict "Open" AI Models Following China's Breakthrough

25.07.2026 05:03

SpaceX has successfully tested the Starship rocket for the first time since its IPO

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026